BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 35358798)

  • 1. Progress and perspective of organoid technology in cancer-related translational medicine.
    Lin Y; Jiang L; He Q; Yuan M; Cao J
    Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
    Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
    OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking the potential of organoids in cancer treatment and translational research: An application of cytologic techniques.
    Abd El-Salam MA; Troulis MJ; Pan CX; Rao RA
    Cancer Cytopathol; 2024 Feb; 132(2):96-102. PubMed ID: 37843532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.
    Novelli G; Spitalieri P; Murdocca M; Centanini E; Sangiuolo F
    Front Cell Dev Biol; 2022; 10():1059579. PubMed ID: 36699015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid technology and applications in cancer research.
    Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
    J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primate Organoids and Gene-Editing Technologies toward Next-Generation Biomedical Research.
    Chen C; Ji W; Niu Y
    Trends Biotechnol; 2021 Dec; 39(12):1332-1342. PubMed ID: 33941418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered organoids for biomedical applications.
    Roberto de Barros N; Wang C; Maity S; Peirsman A; Nasiri R; Herland A; Ermis M; Kawakita S; Gregatti Carvalho B; Hosseinzadeh Kouchehbaghi N; Donizetti Herculano R; Tirpáková Z; Mohammad Hossein Dabiri S; Lucas Tanaka J; Falcone N; Choroomi A; Chen R; Huang S; Zisblatt E; Huang Y; Rashad A; Khorsandi D; Gangrade A; Voskanian L; Zhu Y; Li B; Akbari M; Lee J; Remzi Dokmeci M; Kim HJ; Khademhosseini A
    Adv Drug Deliv Rev; 2023 Dec; 203():115142. PubMed ID: 37967768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biobanking of human gut organoids for translational research.
    Perrone F; Zilbauer M
    Exp Mol Med; 2021 Oct; 53(10):1451-1458. PubMed ID: 34663935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in Translational Science for Esophageal and Gastric Cancers.
    Hompe ED; Sachdeva UM
    Surg Oncol Clin N Am; 2024 Jul; 33(3):571-581. PubMed ID: 38789199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid technology: Current standing and future perspectives.
    Shariati L; Esmaeili Y; Haghjooy Javanmard S; Bidram E; Amini A
    Stem Cells; 2021 Dec; 39(12):1625-1649. PubMed ID: 33786925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoids: The current status and biomedical applications.
    Yang S; Hu H; Kung H; Zou R; Dai Y; Hu Y; Wang T; Lv T; Yu J; Li F
    MedComm (2020); 2023 Jun; 4(3):e274. PubMed ID: 37215622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human organoids-on-chips for biomedical research and applications.
    Wang H; Ning X; Zhao F; Zhao H; Li D
    Theranostics; 2024; 14(2):788-818. PubMed ID: 38169573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer research using organoid technology.
    Kretzschmar K
    J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer modeling meets human organoid technology.
    Tuveson D; Clevers H
    Science; 2019 Jun; 364(6444):952-955. PubMed ID: 31171691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Cancer Medicine: An Organoid Approach.
    Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
    Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.